- Home
- HOTH vs NURO Comparison
HOTH vs NURO Comparison
Compare HOTH & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- NURO
- Stock Information
- Founded
- HOTH 2017
- NURO 1996
- Country
- HOTH United States
- NURO United States
- Employees
- HOTH N/A
- NURO N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- HOTH Health Care
- NURO Health Care
- Exchange
- HOTH Nasdaq
- NURO Nasdaq
- Market Cap
- HOTH 7.6M
- NURO 7.6M
- IPO Year
- HOTH 2019
- NURO N/A
- Fundamental
- Price
- HOTH $0.82
- NURO $3.93
- Analyst Decision
- HOTH Strong Buy
- NURO
- Analyst Count
- HOTH 4
- NURO 0
- Target Price
- HOTH $4.75
- NURO N/A
- AVG Volume (30 Days)
- HOTH 996.3K
- NURO 20.7K
- Earning Date
- HOTH 11-12-2024
- NURO 11-05-2024
- Dividend Yield
- HOTH N/A
- NURO N/A
- EPS Growth
- HOTH N/A
- NURO N/A
- EPS
- HOTH N/A
- NURO N/A
- Revenue
- HOTH N/A
- NURO $3,767,764.00
- Revenue This Year
- HOTH N/A
- NURO N/A
- Revenue Next Year
- HOTH N/A
- NURO N/A
- P/E Ratio
- HOTH N/A
- NURO N/A
- Revenue Growth
- HOTH N/A
- NURO N/A
- 52 Week Low
- HOTH $0.58
- NURO $2.66
- 52 Week High
- HOTH $1.73
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- HOTH 42.93
- NURO 50.39
- Support Level
- HOTH $0.83
- NURO $3.56
- Resistance Level
- HOTH $0.90
- NURO $3.80
- Average True Range (ATR)
- HOTH 0.09
- NURO 0.32
- MACD
- HOTH -0.01
- NURO -0.01
- Stochastic Oscillator
- HOTH 10.18
- NURO 47.01
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.